89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study

NCT05955833 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Metastatic Breast Cancer
HER2-positive Breast Cancer
Gastric Cancer
Metastatic Gastric Cancer
HER2-positive Gastric Cancer

Interventions

DIAGNOSTIC_TEST: 89Zr-DFO*-trastuzumab PET scan

Sponsor

Amsterdam UMC, location VUmc

Collaborators

[object Object]